Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group

No Thumbnail Available

Authors

Rebbeck, T. R.
Friebel, T.
Wagner, T.
Lynch, H. T.
Garber, J. E.
Daly, M. B.
Isaacs, C.
Olopade, O. I.
Neuhausen, S. L.
van 't Veer, L.

Issue Date

2005

Volume

23

Issue

31

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Rebbeck, T. R.; Friebel, T.; Wagner, T.; Lynch, H. T.; Garber, J. E.; Daly, M. B.; Isaacs, C.; Olopade, O. I.; Neuhausen, S. L.; van 't Veer, L.; Eeles, R.; Evans, D. G.; Tomlinson, G.; Matloff, E.; Narod, S. A.; Eisen, A.; Domchek, S.; Armstrong, K.; Weber, B. L. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. Journal of Clinical Oncology. 2005, NOV 1. 23(31):7804-7810.

Publisher

License

Journal

Volume

Issue

PubMed ID

DOI

Identifier

ISSN

0732-183X
1527-7755

EISSN

Collections